E. R. SQUIBB AND SONS, LLC & ORS. vs ZYDUS LIFESCIENCES LIMITED

Judgment text excerpt

$~ * IN THE HIGH COURT OF DELHI AT NEW DELHI + CS(COMM) 376/2024 & I.A. 10533/2024 E. R. SQUIBB AND SONS, LLC & ORS. .....Plaintiffs Through: Mr. Sandeep Sethi, Sr. Advocate, Mr. P.S. Raman, Sr. Advocate, Mr. Amit Sibal, Sr. Advocate with Mr. Pravin Anand, Ms. Archana Shanker, Ms. Prachi Agarwal, Mr. Devinder Rawat, Ms. Elisha Sinha and Mr. Manan Mondal, Advocates versus ZYDUS LIFESCIENCES LIMITED .....Defendant Through: Mr. Harish Salve, Sr. Advocate, Mr. Dushyant Dave, Sr. Advocate, Mr. Rajiv Nayar, Sr. Advocate, Mr. Dayan Krishnan, Sr. Advocate with Mr. Adarsh Ramanujan, Ms. Bitika Sharma, Ms. Vrinda Pathak, Ms. Sandhya Kukreti, Mr. Rajnish Kumar, Ms. S.L. Soujanya, Mr. Parth Singh and Mr. Manjunathan P.S., Advocates CORAM: HON'BLE MS. JUSTICE MINI PUSHKARNA JUDGMENT % 18.07.2025 MINI PUSHKARNA, J: I.A. 10533/2024 (Application under Order XXXIX Rules 1 and 2, read with Section 151 of the Code of Civil Procedure, 1908 for injunction) Introduction: 1. By way of the present judgment, this Court shall decide the Signature Not Verified Digitally Signed CS(COMM) 376/2024 Page 1 of 101 By:HARIOM SHARMA Signing Date:18.07.2025 20:46:14 application of the plaintiffs for injunction, being I.A. 10533/2024. 2. The present suit has been filed seeking permanent injunction for restraining infringement of Indian Patent No. IN 340060 (“IN „060”), which is titled as, ―Human Monoclonal Antibodies to Programmed Death 1 (PD-1) for use in treating Cancer‖ (“suit patent”). The suit patent is registered in the name of the plaintiffs and is currently valid and subsisting. 3. The suit patent covers and claims a monoclonal antibody, also known as „Nivolumab‟ or „5C4‟, in the complete specification of IN „060. Nivolumab is a therapeutic antibody used in the treatment of various forms of cancer.